Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 9th May 2024 CYCC stock ended at $2.31. This is 0.431% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 14.48% from a day low at $2.27 to a day high of $2.60.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Nov 25, 2016 $4.26 $4.45 $4.26 $4.40 32 503
Nov 23, 2016 $4.25 $4.37 $4.21 $4.29 60 800
Nov 22, 2016 $4.56 $4.72 $4.20 $4.29 100 863
Nov 21, 2016 $4.51 $5.60 $4.13 $4.62 338 684
Nov 18, 2016 $5.42 $5.60 $4.50 $4.58 425 548
Nov 17, 2016 $3.62 $5.41 $3.37 $5.38 850 104
Nov 16, 2016 $3.74 $3.75 $3.51 $3.67 58 588
Nov 15, 2016 $3.90 $3.99 $3.62 $3.75 73 440
Nov 14, 2016 $3.66 $3.91 $3.49 $3.91 77 397
Nov 11, 2016 $3.72 $3.74 $3.41 $3.59 69 510
Nov 10, 2016 $3.94 $3.99 $3.47 $3.67 133 548
Nov 09, 2016 $3.35 $3.95 $3.35 $3.87 212 582
Nov 08, 2016 $3.40 $3.41 $3.05 $3.25 106 270
Nov 07, 2016 $3.45 $3.45 $3.27 $3.33 25 600
Nov 04, 2016 $3.38 $3.48 $3.31 $3.35 32 800
Nov 03, 2016 $3.46 $3.79 $3.36 $3.36 27 200
Nov 02, 2016 $3.68 $3.72 $3.35 $3.46 99 200
Nov 01, 2016 $3.94 $3.94 $3.62 $3.62 92 100
Oct 31, 2016 $3.93 $3.99 $3.84 $3.94 24 700
Oct 28, 2016 $4.07 $4.08 $3.80 $3.93 133 600
Oct 27, 2016 $4.37 $4.37 $4.06 $4.10 207 700
Oct 26, 2016 $4.52 $4.64 $4.27 $4.37 47 000
Oct 25, 2016 $4.97 $4.99 $4.52 $4.53 181 600
Oct 24, 2016 $4.99 $5.14 $4.85 $4.89 145 400
Oct 21, 2016 $5.00 $5.19 $4.85 $4.93 124 100
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT